Cours Adynxx, Inc. Other OTC
Actions
ADYX
US00784D1037
Recherche biotechnologique et médicale
CA 2017 | - | CA 2018 | - | Capitalisation | 5 4,42 |
---|---|---|---|---|---|
Résultat net 2017 | -11 M -9,72 M | Résultat net 2018 | -5 M -4,42 M | VE / CA 2017 * | - |
Trésorerie nette 2017 * | - 0 | Trésorerie nette 2018 * | - 0 | VE / CA 2018 * | - |
PER 2017 * |
-
| PER 2018 * |
-
| Employés | - |
Rendement 2017 * |
-
| Rendement 2018 * |
-
| Flottant | 100% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Julien Mamet
FOU | Founder | - | 01/10/07 |
Rick Orr
CEO | Chief Executive Officer | - | 01/12/10 |
Dina Gonzalez
DFI | Director of Finance/CFO | - | 01/01/10 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Eckard Weber
BRD | Director/Board Member | 73 | - |
Stanley Abel
BRD | Director/Board Member | - | 01/01/08 |
Dennis Podlesak
CHM | Chairman | 66 | - |
Varia. 1 janv. | Capi. | |
---|---|---|
+34,01% | 51,07 Md | |
+33,84% | 38,86 Md | |
-8,02% | 38,78 Md | |
-8,98% | 26,69 Md | |
+12,56% | 26,35 Md | |
-19,62% | 19,46 Md | |
+39,18% | 13,58 Md | |
+31,47% | 12,46 Md | |
-3,40% | 11,75 Md |